All articles by Manish Kumar
Manish Kumar
Evonik and ICIG complete sale of superabsorbents business
ICIG takes over production facilities at five locations in Germany and the United States
LHSC, SHC Canada partner on orthopaedic care, research, and education
Under the partnership, families in southwestern Ontario will get access to specialised paediatric orthopaedic care while Shriners Hospitals will continue to handle more complex cases
WuXi announces first high-scale GMP manufacturing using WuXiUI platform
Launched in 2023, the WuXiUI platform enhances productivity across various CHO and other mammalian cell lines to support global clients in meeting the growing demand for therapeutic proteins and antibodies
Cleveland Clinic joins the Gold Kidney Health Plan Network
Supporting Medicare-Eligible Florida Residents with Chronic Conditions
Vion Biosciences acquires immunoassay kits developer Ansh Labs
Ansh’s products are employed in academic research, clinical laboratories, and pharmaceutical development, supporting studies in areas such as fertility, pregnancy, bone metabolism, obesity, and cancer
Pensar Medical partners with Centurion Therapeutics for innovative negative pressure wound therapy system
The Microdoc sNPWT system offers cost-effective and efficient treatment for chronic and acute wounds
Life Molecular wins FDA fast track status for [18F]PI-2620 imaging agent
The investigational, advanced F18-labeled PET imaging agent has received fast track status for clinical development in AD, progressive supranuclear palsy, and corticobasal degeneration
Pristine selects AcuityMD’s platform to rollout Summit arthroscope
After the initial phase, the company has teamed up with AcuityMD to support a full-scale launch of the single-use surgical arthroscope specifically for ambulatory surgery centres
ClariMed expands European presence with new office in Leeds, UK
This strategic expansion strengthens ClariMed’s European footprint and enhances its ability to serve global clients while capitalizing on the region’s thriving healthcare innovation ecosystem
Ensysce secures $14m NIH grant to develop PF614-MPAR opioid
The three-year funding will support Phase 1b PF614-MPAR-102 trial, building on results from PF614-MPAR-101, to establish PF614-MPAR as the first opioid with oral overdose protection